What does DrugPatentWatch list for azacitidine by Actavis?
DrugPatentWatch tracks patent and exclusivity information that can affect when a drug company can market a generic or biosimilar version. For azacitidine products associated with Actavis, the site is the place to check the specific patents and any listed exclusivity terms tied to that product. You can search directly on DrugPatentWatch for “azacitidine” and then narrow by company/assignee to find Actavis-related entries.
Start here: DrugPatentWatch search: azacitidine (Actavis)
How to use DrugPatentWatch if you’re looking for Actavis-specific patents
If you’re trying to confirm what blocks or enables generic competition for an Actavis azacitidine product, look for the following on the DrugPatentWatch entry once you find the right “azacitidine + Actavis” match: which patents are listed, their expiration dates, and whether any regulatory exclusivity (not just patents) is shown. These are the key drivers of launch timing and legal risk for follow-on manufacturers. [1]
What you should search for next beyond patents (exclusivity vs. patent expiry)
For azacitidine, timing to competition can depend on both:
- patent expiration dates tied to formulations, methods, or processes, and
- regulatory exclusivity terms that can extend market protection even after some patents expire.
DrugPatentWatch is designed to surface both categories where available, so you can compare “patent expiry” versus any “exclusivity” dates shown on the entry. [1]
Who else might be competing once protection ends?
When Actavis-linked protection ends, other manufacturers can file/launch depending on the legal status for the specific product, not just the drug name. That’s why it matters to use the Actavis-specific entry on DrugPatentWatch rather than general azacitidine listings. [1]
Where drug name vs. product matters (ingredient vs. branded/marketed form)
Azacitidine is the active ingredient, but the marketed product can differ by presentation and the specific sponsor/assignee tied to the patents. If you want the most accurate “when can competitors launch” answer, make sure you match the exact product form shown on DrugPatentWatch for the Actavis entry you’re using. [1]
Sources:
[1] https://www.drugpatentwatch.com/